TITLE

PHF6 mutations in adult acute myeloid leukemia

AUTHOR(S)
Van Vlierberghe, P.; Patel, J.; Abdel-Wahab, O.; Lobry, C.; Hedvat, C. V.; Balbin, M.; Nicolas, C.; Payer, A. R.; Fernandez, H. F.; Tallman, M. S.; Paietta, E.; Melnick, A.; Vandenberghe, P.; Speleman, F.; Aifantis, I.; Cools, J.; Levine, R.; Ferrando, A.
PUB. DATE
January 2011
SOURCE
Leukemia (08876924);Jan2011, Vol. 25 Issue 1, p130
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
Loss of function mutations and deletions encompassing the plant homeodomain finger 6 (PHF6) gene are present in about 20% of T-cell acute lymphoblastic leukemias (ALLs). Here, we report the identification of recurrent mutations in PHF6 in 10/353 adult acute myeloid leukemias (AMLs). Genetic lesions in PHF6 found in AMLs are frameshift and nonsense mutations distributed through the gene or point mutations involving the second plant homeodomain (PHD)-like domain of the protein. As in the case of T-ALL, where PHF6 alterations are found almost exclusively in males, mutations in PHF6 were seven times more prevalent in males than in females with AML. Overall, these results identify PHF6 as a tumor suppressor gene mutated in AML and extend the role of this X-linked tumor suppressor gene in the pathogenesis of hematologic tumors.
ACCESSION #
57323961

 

Related Articles

  • Relative fitness of hematopoietic progenitors influences leukemia progression. Porter, C. C.; Baturin, D.; Choudhary, R.; DeGregori, J. // Leukemia (08876924);May2011, Vol. 25 Issue 5, p891 

    A letter to the editor is presented which discusses the role of hematopoietic progenitor cells (HPC) in leukemogenesis.

  • Sequencing a mouse acute promyelocytic leukemia genome reveals genetic events relevant for disease progression. Wartman, Lukas D.; Larson, David E.; Zhifu Xiang; Li Ding; Ken Chen; Ling Lin; Cahan, Patrick; Klco, Jeffery M.; Welch, John S.; Cheng Li; Payton, Jacqueline E.; Uy, Geoffrey L.; Varghese, Nobish; Ries, Rhonda E.; Hoock, Mieke; Koboldt, Daniel C.; McLellan, Michael D.; Schmidt, Heather; Fulton, Robert S.; Abbott, Rachel M. // Journal of Clinical Investigation;Apr2011, Vol. 121 Issue 4, p1445 

    Acute promyelocytic leukemia (APL) is a subtype of acute myeloid leukemia (AML). It is characterized by the t(15;17)(q22;q11.2) chromosomal translocation that creates the promyelocytic leukemia-retinoic acid receptor α (PML-RARA) fusion oncogene. Although this fusion oncogene is known to...

  • HIV-1 Rev-binding protein accelerates cellular uptake of iron to drive Notch-induced T cell leukemogenesis in mice. Khwaja, Shariq S.; Hudan Liu; Caili Tong; Fang Jin; Pear, Warren S.; van Deursen, Jan; Bram, Richard J.; Liu, Hudan; Tong, Caili; Jin, Fang // Journal of Clinical Investigation;Jul2010, Vol. 120 Issue 7, p2537 

    Somatic activating mutations in Notch1 contribute to the pathogenesis of T cell acute lymphoblastic lymphoma (T-ALL), but how activated Notch1 signaling exerts this oncogenic effect is not completely understood. Here we identify HIV-1 Rev-binding protein (Hrb), a component of the...

  • Phenotypic effect correlating with loss of a novel tumor suppressor gene: towards cloning by complementation. Cook, W D; Alexander, B J // Leukemia (08876924);Dec98, Vol. 12 Issue 12, p1937 

    We intend to use a gene complementation approach to clone a tumor suppressor gene on mouse chromosome 2, the loss of which contributes to myeloid leukemia. An in vitro model system has been generated using a clonal cell line, in which tumorigenic chromosomal lesions have been selected along with...

  • EVI1 induces myelodysplastic syndrome in mice. Buonamici, Silvia; Li, Donglan; Chi, Yiqing; Zhao, Rui; Wang, Xuerong; Brace, Larry; Ni, Hongyu; Saunthararajah, Yogen; Nucifora, Giuseppina // Journal of Clinical Investigation;Sep2004, Vol. 114 Issue 5, p713 

    Myelodysplasia is a hematological disease in which genomic abnormalities accumulate in a hematopoietic stem cell leading to severe pancytopenia, multilineage differentiation impairment, and bone marrow (BM) apoptosis. Mortality in the disease results from pancytopenia or transformation to acute...

  • Chronic myeloid leukemia: mechanisms of blastic transformation. Perrotti, Danilo; Jamieson, Catriona; Goldman, John; Skorski, Tomasz // Journal of Clinical Investigation;Jul2010, Vol. 120 Issue 7, p2254 

    The BCR-ABL1 oncoprotein transforms pluripotent HSCs and initiates chronic myeloid leukemia (CML). Patients with early phase (also known as chronic phase [CP]) disease usually respond to treatment with ABL tyrosine kinase inhibitors (TKIs), although some patients who respond initially later...

  • A noninhibitory mutant of the caveolin-1 scaffolding domain enhances eNOS-derived NO synthesis and vasodilation in mice. Bernatchez, Pascal; Sharma, Arpeeta; Bauer, Philip M.; Marin, Ethan; Sessa, William C. // Journal of Clinical Investigation;Sep2011, Vol. 121 Issue 9, p3747 

    Aberrant regulation of eNOS and associated NO release are directly linked with various vascular diseases. Caveolin-1 (Cav-1), the main coat protein of caveolae, is highly expressed in endothelial cells. Its scaffolding domain serves as an endogenous negative regulator of eNOS function....

  • Cooperation between RUNX1-ETO9a and Novel Transcriptional Partner KLF6 in Upregulation of Alox5 in Acute Myeloid Leukemia. DeKelver, Russell C.; Lewin, Benjamin; Lam, Kentson; Komeno, Yukiko; Yan, Ming; Rundle, Chandler; Lo, Miao-Chia; Zhang, Dong-Er // PLoS Genetics;Oct2013, Vol. 9 Issue 10, p1 

    Fusion protein RUNX1-ETO (AML1-ETO, RUNX1-RUNX1T1) is expressed as the result of the 8q22;21q22 translocation [t(8;21)], which is one of the most common chromosomal abnormalities found in acute myeloid leukemia. RUNX1-ETO is thought to promote leukemia development through the aberrant regulation...

  • Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status. Zhe Jiang; Tao Deng; Jones, Robert; Huiqin Li; Herschkowitz, Jason I.; Liu, Jeff C.; Weigman, Victor J.; Ming-Sound Tsao; Lane, Timothy F.; Perou, Charles M.; Zacksenhaus, Eldad; Jiang, Zhe; Deng, Tao; Li, Huiqin; Tsao, Ming-Sound // Journal of Clinical Investigation;Sep2010, Vol. 120 Issue 9, p3296 

    Breast cancer is a highly heterogeneous disease, with several different subtypes being characterized by distinct histology, gene expression patterns, and genetic alterations. The tumor suppressor gene retinoblastoma 1 (RB1) is frequently lost in both luminal-B and triple-negative tumor (TNT;...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics